Go to the list of all blogs
Allana's Avatar
published in Blogs
Nov 07, 2026
TickeronGET DAILY SIGNALS
Vanguard Mega Cap Value ETF (MGV) Delivers +1.9% Monthly Gain in Defensive Value Setup

Vanguard Mega Cap Value ETF (MGV) Delivers +1.9% Monthly Gain in Defensive Value Setup

Key Takeaways

  • MGV is a passively managed exchange-traded fund (ETF) that tracks the CRSP US Mega Cap Value Index, holding roughly 128 of the largest, most inexpensive U.S. mega-cap stocks.
  • Financials is the largest sector weight at about 24%, followed by healthcare, information technology, and industrials, giving the fund a distinctly defensive, value-oriented profile.
  • The fund carries a 0.05% expense ratio and manages more than $13 billion in assets under management (AUM).
  • Over the past 30 days, MGV advanced about 1.9%, while the trailing three-month period was essentially flat at roughly -0.4%.
  • The range-bound, lower-volatility behavior reflects a sector tilt toward financials, healthcare, and consumer staples rather than high-growth technology.
  • Largest holdings include JPM, XOM, MU, JNJ, and WMT.
  • For additional detail on this ticker, explore dedicated Price Targets and Forecast pages.
  • For automated, AI-driven trading ideas, explore Trending AI Robots.

Understanding the Vanguard Mega Cap Value ETF (MGV)

The Vanguard Mega Cap Value ETF seeks to track the performance of the CRSP US Mega Cap Value Index, a float-adjusted, market-capitalization-weighted benchmark of the largest U.S. companies that screen as value-oriented. The index selects and weights holdings using several value factors, including book-to-price, earnings-to-price, dividends-to-price, and sales-to-price ratios, which means the portfolio skews toward established, cash-generative businesses trading at relatively modest valuations.

The fund is structured as a passive index ETF and holds approximately 128 securities, with no single position exceeding roughly 5% of assets. Its ten largest holdings account for about 27% of the portfolio, a modest concentration for a mega-cap vehicle. Sector allocation is dominated by financials (about 24%), followed by healthcare (around 18%), information technology (about 16%), industrials (around 13%), and consumer staples (roughly 10%). Energy, consumer discretionary, communication services, materials, and utilities make up smaller weights. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Among its largest positions are JPMorgan Chase, Berkshire Hathaway, ExxonMobil, Micron Technology, Johnson & Johnson, Walmart, AbbVie, Costco Wholesale, Bank of America, and Cisco Systems. The fund carries a 0.05% expense ratio, among the lowest in the large-cap value category, and a 12-month trailing dividend yield near 1.9%. This broad, inexpensive, income-oriented structure helps explain the fund's comparatively stable, range-bound behavior relative to growth-tilted peers.

Industry and Thematic Landscape

MGV operates at the intersection of several durable investment themes: large-cap value investing, dividend income, and defensive sector exposure. The value segment has benefited in recent years from a rotation away from high-multiple growth stocks toward companies with tangible cash flows and stronger balance sheets. Financials, the fund's largest sleeve, have been supported by a higher-for-longer interest-rate backdrop that can bolster net interest margins for banks and insurers.

Healthcare and consumer staples provide ballast through less economically sensitive earnings, while the information technology allocation—anchored in part by memory-chip maker Micron Technology—introduces a cyclical growth element to an otherwise defensive portfolio. Energy exposure through ExxonMobil and Chevron ties a portion of the fund to oil and gas price trends. The macroeconomic environment, including inflation readings, Federal Reserve policy expectations, and credit conditions, remains a key swing factor for the financial-heavy composition of the index.

Performance and Positioning Snapshot

Over the most recent 30-day period, MGV rose from about $162.28 to roughly $165.33, a gain of approximately 1.9%. The move was gradual rather than trend-driven, punctuated by a brief dip toward the $160 level in early October followed by a steady recovery into November. Over the trailing three-month window, the fund was essentially unchanged, slipping about 0.4% from roughly $166.04 to $165.33.

This range-bound profile is consistent with the fund's lower-beta, value-tilted construction. The broad 52-week trading range—from a low near $135.26 to a high around $169.84—underscores the fund's steady upward drift over the longer term, even as near-term price action consolidated. Strength in large banks and healthcare names has provided support, while the semiconductor holdings, led by Micron, have contributed a more volatile, cyclical influence to recent performance.

2026 Outlook and Key Factors to Monitor

Looking ahead, several structural factors are likely to shape MGV's trajectory through 2026. Interest-rate expectations and Federal Reserve policy remain central, given the fund's heavy financials allocation; the pace and direction of any rate adjustments will influence bank profitability and insurer returns. Inflation trends and their effect on real yields will similarly matter for the value and dividend-income characteristics of the portfolio.

Earnings cycles among major holdings—particularly large banks, energy producers, and the semiconductor exposure—will drive a meaningful portion of performance. Sector rotation between value and growth styles, institutional capital flows into and out of passive value funds, and the competitive landscape among low-cost large-cap value ETFs are additional considerations. Regulatory developments affecting financials and healthcare, along with energy commodity prices, round out the key themes. While no price prediction is warranted, these factors will collectively determine whether the fund's recent consolidation gives way to renewed momentum or extended sideways trading.

Using Tickeron’s AI Tools for Deeper Analysis

In my own workflow, I frequently rely on Tickeron’s AI Screener when evaluating ETFs like this one. It lets me quickly filter thousands of securities by technical indicators, fundamentals, volatility, and AI signals to spot comparable opportunities or confirm positioning within the broader market. The platform’s ability to sort by industry and risk metrics gives a structured way to move beyond single-ticker review and identify potential additions or hedges without manual effort. For anyone looking to systematize their research, it serves as a practical starting point that integrates well with traditional analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MGV

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


MGV in -3.50% downward trend, sliding for three consecutive days on November 06, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MGV declined for three days, in 198 of 278 cases, the price declined further within the following month. The odds of a continued downward trend are 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for MGV moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 50 similar instances where the indicator moved out of overbought territory. In 32 of the 50 cases, the stock moved lower in the following days. This puts the odds of a move lower at 64%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 69 cases where MGV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MGV as a result. In 55 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for MGV turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 35 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.

MGV broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

MGV moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MGV crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +1.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where MGV advanced for three days, in 284 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

The Aroon Indicator entered an Uptrend today. In 279 of 354 cases where MGV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Notable companies

The most notable companies in this group are Walmart (NASDAQ:WMT), JPMorgan Chase & Co (NYSE:JPM), Micron Technology (NASDAQ:MU), ExxonMobil Holdings Corporation (NYSE:XOM), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Costco Wholesale Corp (NASDAQ:COST), Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG).

Industry description

The investment seeks the performance of the CRSP U.S. Mega Cap Value Index. The fund employs an indexing investment approach designed to track the performance of the index. The index is a float-adjusted, market-capitalization-weighted index designed to measure equity market performance of mega-capitalization value stocks in the United States. The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Market Cap

The average market capitalization across the Vanguard Morningstar Mega Cap Value ETF (MGV) ETF is 176.54B. The market cap for tickers in the group ranges from 61.95B to 995.84B. WMT holds the highest valuation in this group at 995.84B. The lowest valued company is BSX at 61.95B.

High and low price notable news

The average weekly price growth across all stocks in the Vanguard Morningstar Mega Cap Value ETF (MGV) ETF was -2%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was 8%. NEM experienced the highest price growth at 13%, while DELL experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Vanguard Morningstar Mega Cap Value ETF (MGV) ETF was -22%. For the same stocks of the ETF, the average monthly volume growth was 22% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 71
P/E Growth Rating: 48
Price Growth Rating: 36
SMR Rating: 45
Profit Risk Rating: 47
Seasonality Score: 15 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category LargeValue

Category
Large Value
Address
Vanguard Health CarePo Box 2600 V26Valley Forge
Phone
N/A
Web
www.vanguard.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of $1.54 billion, reflecting approximately 74% year-over-year growth. Consensus earnings per share (EPS) forecast stands at $0.28, up over 115% from the prior year.
Analysts expect Q1 2026 revenue of $3.00 billion, up 8% from $2.77 billion in the year-ago quarter. Consensus earnings per share (EPS) estimate stands at $4.31, reflecting steady profitability from the cystic fibrosis (CF) portfolio.